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Objectives: Cardiogenic shock constitutes the final common path-
way of cardiac dysfunction associated with tissue hypoperfusion 
and organ failure. Besides treatment of the underlying cause, 
temporary mechanical circulatory support serves as a supportive 
measure. Extracorporeal membrane oxygenation can effectively 
prevent hypoxemia and end-organ dysfunction, but knowledge 
about patient selection, risks, and complications remains sparse.
Data Sources: Clinical observation.
Study Selection: Case report and review of the literature.
Data Extraction: Relevant clinical information. Online databases, 
including PubMed, Web of Science, Scopus, and OVID, were 
searched for previous publications.
Data Synthesis: We report six cases of patients in refractory 
cardiogenic shock receiving emergency femoral veno-arterial 
extracorporeal membrane oxygenation support complicated by 
echocardiographic evidence of absent blood flow, sedimentation, 
and thrombus formation in the aortic root.
Conclusions: Patients in cardiogenic shock who require femoral 
veno-arterial extracorporeal membrane oxygenation support are 
at risk of developing a state of nonejecting heart with thrombus 
formation in the aortic root. Echocardiography is the cornerstone 
of diagnosis and documentation of treatment effects. Depending 
on the likelihood of the presence of clinically relevant throm-
botic material in the aortic root, we propose a treatment algo-
rithm for this group of high-risk patients. (Crit Care Med 2018; 
46:e459–e464)
Key Words: aortic thrombus; blood stasis; cardiogenic shock; 
extracorporeal membrane oxygenation; nonbeating heart
Cardiogenic shock constitutes the final common path-way of cardiac dysfunction associated with tissue hypo-perfusion and subsequent organ failure (1). Besides 
treatment of the underlying cause, for example, coronary 
revascularization (2), temporary mechanical circulatory sup-
port is a measure of supportive care in patients with refractory 
shock or cardiac arrest (3–5). Although extracorporeal mem-
brane oxygenation (ECMO) can effectively prevent hypoxemia 
and end-organ dysfunction (6, 7), no randomized trial has 
demonstrated reduced mortality or morbidity in cardiogenic 
shock. ECMO use in cardiac arrest is referred to as “extracor-
poreal-cardiopulmonary resuscitation (E-CPR)” (3, 4).
Intracardiac thrombus is a common finding in patients fol-
lowing large myocardial infarction or with severely depressed 
left ventricular function. It is conceivable that reduced flow 
across the aortic valve during ECMO support favors clot for-
mation not only in the left ventricle (LV) but also in the aortic 
root. The reported prevalence of intracardiac thrombus was 
3.9% (3/77) in a recent single-center observational study (8), 
and a case series presented nine cases with intracardiac throm-
bus formation and five patients with thrombus in the aortic 
root during ECMO (9). The transition from spontaneous echo 
contrast to thrombus in formation to a firm thrombotic clot is 
time dependent and may even occur in the presence of thera-
peutic anticoagulation. During femoral veno-arterial ECMO, 
reversed blood flow in the thoracic aorta and aortic arch 
together with absent blood flow across the aortic valve favors 
blood sedimentation and thrombus formation in the aortic DOI: 10.1097/CCM.0000000000002966
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root. The loss of peripheral arterial pulsatility due to a closed 
aortic valve is therefore an alarm signal during ECMO support.
Here, we report a case series of six patients on femoral veno-
arterial ECMO due to cardiogenic shock with consequent 
thrombus formation in the aortic root despite adequate anti-
coagulation, review the previously published cases and present 
our treatment algorithm for this condition.
CASE 1 
A 26-year-old female patient was transferred to our center 
by air medical services under veno-arterial ECMO (E-CPR) 
from another hospital. Femoral veno-arterial ECMO (Maquet 
Cardiohelp ECMO system; Getinge Group AB, Göteborg, 
Sweden) had been initiated during cardiopulmonary resus-
citation (CPR) following admittance to the ICU for respira-
tory failure. At our hospital, workup raised the suspicion 
of drug-induced hypersensitivity reaction (Drug Reaction 
with Eosinophilia and Systemic Symptoms) with myocar-
dial involvement most likely following “Minocycline” treat-
ment for acne vulgaris. Endomyocardial biopsy confirmed 
the diagnosis revealing necrotizing myocarditis with eosino-
philia. A transoesophageal echocardiography (TEE) showed 
severe dysfunction of both ventricles, thickened myocardium 
(most likely due to edema [10]), and a nonopening aortic 
valve with echocardiographic features of blood stasis and 
beginning thrombus formation in the aortic root. Subse-
quent TEE examinations documented progressive thrombus 
formation in the aortic root and subsequently also in the LV 
(Fig. 1; and  Supplementary Video 1, Supplemental Digital 
Content 1, http://links.lww.com/CCM/D169). Repeated cere-
bral MRI scans showed a star field pattern in the susceptibility 
weighted imaging sequence and signs of severe ischemic cerebral 
injury with persistently poor neurologic status not explained 
by the right-sided parieto-occipital stroke ( Supplementary 
Fig. 1, Supplemental Digital Content 2, http://links.lww.com/
CCM/D170--legend, Supplemental Digital Content 9, http://
links.lww.com/CCM/D177).
CASE 2 
A 19-year-old female patient was admitted to the emergency 
department (ED) by emergency medical services (EMS) after 
she had collapsed in the public followed by a short generalized 
seizure. She remained unconscious with a Glasgow Coma Scale 
score of 3. Prehospital electrocardiogram (ECG) showed a slow 
ventricular rhythm at around 30/min without visible p-waves 
and intermittent episodes of nonsustained ventricular tachycar-
dia (VT). At admission, the patient was in profound shock with 
absent peripheral pulses and agonal breathing. After 15 minutes of 
CPR and orotracheal intubation, mechanical circulatory support 
with femoral veno-arterial ECMO was initiated in the cardiac 
catheterization laboratory. Local standard operating procedures 
include administration of a bolus of unfractionated heparin 
(UFH) followed by an infusion of UFH with a target activated 
partial thromboplastin time of 50–80 seconds. A transthoracic 
echocardiogram revealed absence of intrinsic LV function and a 
persistently closed aortic valve with blood stasis in the ascending 
aorta. Sedimentation of blood 
was particularly pronounced in 
the noncoronary cusp. Repeated 
TEE examinations were highly 
suggestive for thrombus forma-
tion in the aortic root (Supple-
mentary Fig. 2, Supplemental 
Digital Content 3, http://links.
lww.com/CCM/D171--legend, 
Supplemental Digital Content 
9, http://links.lww.com/CCM/
D177; and Supplementary 
Video 2, Supplemental Digi-
tal Content 4, http://links.lww.
com/CCM/D172). The arte-
rial ECMO cannula was surgi-
cally switched to the ascending 
aorta, and an additional venting 
cannula was placed in the right 
upper pulmonary vein. During 
surgery, resumption of aortic 
valve opening with no macro-
scopic thrombus on the valve 
was observed. After 50 hours, 
the patients’ cardiac function 
had fully recovered, and ECMO 
therapy was successfully ended. 
No obvious embolic end-organ 
Figure 1. Transoesophageal echocardiogram, mid-oesophageal long axis view. The aortic valve remains closed 
throughout the electrical cardiac cycle. Thrombus is seen in the aortic root (*) and in the left ventricle (+).  
bpm = beats/min, G = general, P = penetration (imaging characteristics), PAT = patient, R = resolution,  
TEE = transoesophageal echocardiography.
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damage was observed, and the patient was discharged without 
neurologic impairment. The cause of the cardiac arrest was self-
intoxication with Taxus baccata.
CASE 3 
A 55-year-old male was brought to the ED by EMS after sud-
den onset of severe thoracic back pain while loading his truck 
followed by syncope. At admission, the patient was awake and 
without neurologic deficits but with persistent thoracic pain. 
During the primary survey, the patient suffered from cardiac 
arrest, and ECG telemetry displayed asystole without p-waves. 
After a brief episode of CPR and orotracheal intubation, return 
of spontaneous circulation (ROSC) was established. Urgent 
coronary angiography revealed severe three-vessel coronary 
artery disease. While advancing the coronary wire through the 
right coronary artery (culprit lesion), a polymorphic VT with 
transition to ventricular fibrillation (VF) occurred. Despite 
termination by external defibrillation with stable sinus rhythm 
thereafter, the patient developed profound cardiogenic shock. 
Femoral veno-arterial ECMO was placed followed by success-
ful percutaneous revascularization. TEE examination dur-
ing the procedure in the cardiac catheterization laboratory 
depicted persistent closure of the aortic valve and minimal 
ventricular contraction. Within minutes, blood in the aortic 
root became hyperechogenic (Fig. 2A; and Supplementary 
Video 3, Supplemental Digital Content 5, http://links.lww.
com/CCM/D173). Administration of inotropic agents and 
reduction of veno-arterial ECMO flow resulted in systolic aor-
tic valve opening and reversal of blood stasis (Fig. 2B; and Sup-
plementary Video 4, Supplemental Digital Content 6, http://
links.lww.com/CCM/D174). The clinical course of the patient 
was favorable with successful weaning from circulatory sup-
port and full neurologic and hemodynamic recovery.
CASE 4 
A 70-year-old male was admitted in cardiogenic shock with 
a history of intermittent typical angina over the past 8 days. 
Sudden onset VF was successfully defibrillated, and follow-
ing a short period of CPR, ROSC was obtained. TEE revealed 
severely impaired systolic LV function with akinesia of the 
anterior wall. The coronary angiogram displayed a ruptured 
plaque in the proximal part of the left anterior descending 
artery with acute vessel occlusion. A percutaneous treatment 
attempt had to be aborted due to severe hemodynamic insta-
bility, and a femoral veno-arterial ECMO was placed. Sub-
sequently, the patient underwent surgical revascularization 
and was transferred to the ICU with absent arterial pulsatil-
ity. Postoperative TEE confirmed a nonejecting heart and was 
suggestive for thrombus formation both in the non- and left-
coronary aortic cusp. Furthermore, a large pericardial effusion 
was diagnosed and subsequently evacuated. After surgical revi-
sion, temporary opening of the aortic valve was documented. 
Despite full mechanical circulatory support, multiple organ 
failure persisted with no signs of LV recovery. Therapeutic 
efforts were halted, and the patient died subsequently.
CASE 5 
A 51-year-old male was brought to the ED after prolonged pre-
hospital CPR with VF as first documented rhythm. On arrival, he 
was unconscious, had cold extremities, and had weak pulses. The 
Figure 2. A, Transoesophageal echocardiogram, modified mid-oesophageal short axis view. Echo contrast is seen in the aortic root (*). The aortic valve is 
not opening throughout the cardiac cycle. B, After inotropic therapy and reduction of veno-arterial extracorporeal membrane oxygenation flow, resumption 
of systolic aortic valve opening and disappearance of echo contrast were observed within 3 min. bpm = beats/min, G = general, P = penetration (imaging 
characteristics), PAT = patient, R = resolution, TEE = transoesophageal echocardiography.
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patient remained hemodynamically and electrically unstable, 
requiring high doses of catecholamines and repeated defibril-
lation. Veno-arterial ECMO was installed followed by coronary 
angiography revealing advanced three-vessel coronary artery 
disease. A later performed TEE was suggestive for thrombotic 
material in the ascending aorta and showed a nonejecting heart. 
Following correction of severe metabolic acidosis, resumption 
of systolic aortic valve opening was documented. The clini-
cal course was unfavorable, and the patient died due to severe 
hypoxic brain injury including persistent myoclonic status.
CASE 6 
A 71-year-old female with epigastric pain for 6 hours was 
transferred from a regional hospital with a lateral ST-segment 
elevation myocardial infarction. During transfer, she suffered 
cardiac arrest and arrived under ongoing mechanical CPR 
using the LUCAS system (Physio-Control Inc., Lund, Swe-
den). In the ED, the patient had ROSC with an initially stable 
rhythm but required inotropic support. Coronary angiogra-
phy showed occlusion of the left main coronary artery. After 
percutaneous revascularization, circulation remained insuf-
ficient despite high dose inotropes, and femoral veno-arterial 
ECMO was initiated. Hemodynamic instability persisted due 
to intra-abdominal blood loss from a liver laceration caused by 
CPR with the LUCAS system. After surgical control of the liver 
bleeding, low-dose heparin infusion was started. TEE showed 
a nonejecting heart and thrombotic material in the aortic 
valve cusps. Cardiac function did not recover, and the patient 
remained in persistent shock despite veno-arterial ECMO 
whereupon therapy was aborted.
DISCUSSION
The reported cases illustrate the development of aortic root 
thrombosis during femoral veno-arterial ECMO support for 
profound cardiogenic shock. So far, aortic root thrombus for-
mation in the setting of femoral veno-arterial ECMO has only 
been described in five patients (for a synthesis, see Supplemen-
tary Table 1, Supplemental Digital Content 7, http://links.lww.
com/CCM/D175) (9). In all cases, we observed an absent ejec-
tion of blood across the nonopening aortic valve into the aorta, 
a state we refer to as “nonejecting heart.” Echocardiographic 
signs of absent blood flow, sedimentation, and thrombus for-
mation in the aortic root were observed in all cases. Application 
of UFH did not prevent the phenomenon, what argues that it is 
a distinct entity different to the well-known ventricular throm-
bus typically seen in large myocardial infarction. More so, we 
hypothesize that in all cases, the mechanism was based on the 
loss of contractility and subsequent blood stasis in the aortic 
root. This is supported by animal models which described an 
increase in LV afterload and a prolonged closure of the aortic 
valve under peripheral veno-arterial ECMO. Our observation 
and interpretation are line with the previously published cases 
(9), where there are nine cases with intracardiac thrombus for-
mation and five patients with thrombus in the aortic root dur-
ing ECMO, but only in one patient, both entities were present. 
Nevertheless, optimal anticoagulation therapy remains crucial 
to prevent other ECMO-associated complications (11, 12).
The reasons for developing a nonejecting heart during 
femoral veno-arterial ECMO are manifold. Severe LV myocar-
dial dysfunction seems to be a prerequisite and can be caused 
by acute inflammation (case 1), intoxication (case 2), severe 
metabolic disturbance (case 5), and most commonly, acute 
ischemia due to coronary heart disease (cases 3–6). Besides LV 
dysfunction, the status of no LV ejection is aggravated by after-
load elevation through inverted blood flow in the aortic arch 
and descending aorta during femoral veno-arterial ECMO 
favoring blood stasis and blood sedimentation in the aortic 
root. This in turn causes a vicious circle with reduced coronary 
blood flow and further impairment of LV function (13–16). 
Besides contractile reserves, LV loading conditions are criti-
cal to maintain forward flow across the aortic valve (17, 18). 
Initiation of femoral veno-arterial ECMO immediately lowers 
LV preload but elevates LV afterload (13, 19, 20). Furthermore, 
hypovolemia as in case 6 and systemic inflammatory response 
syndrome reduce preload. LV filling may additionally be 
impaired in patients with local pericardial hematoma or peri-
cardial effusion (case 4) and patients with progressive right 
ventricular (RV) failure, for example, due to pulmonary embo-
lism, RV infarction or inadequately high intrathoracic pressure 
under mechanical ventilation (11, 12, 21–23).
Within minutes after persistent nonopening of the aortic 
valve, blood stasis and sedimentation in the aortic root can be 
observed. This phenomenon seems to be reversible once the 
aortic valve reopens (case 3). Absent ejection and the obser-
vation of spontaneous echo contrast do not equal the pres-
ence of clinically relevant thrombus. However, spontaneous 
echo contrast increases the risk for intracardiac thrombi and 
strokes (24). In cases 2 and 3, intermittent stasis and spontane-
ous echo contrast in the aortic root were documented without 
resulting embolic complications and full clinical recovery of 
the patients. The length of a nonejecting phase likely affects 
the risk of actual thrombus formation, and even rare sporadic 
LV strokes with small ejected volumes may prevent the pro-
gression from the phenomenon of echo contrast to the pres-
ence of clinically relevant thrombotic material in the aortic 
root (Supplementary Table 2, Supplemental Digital Content 
8, http://links.lww.com/CCM/D176). On the other hand, even 
a single LV forward stroke volume across the aortic valve can 
cause devastating embolic complications once actual throm-
botic material is present in the aortic cusps.
In situations with undetectable pulsatile flow in the periph-
eral arterial blood pressure tracing, we recommend to continue 
treatment based on the presented algorithm (Fig. 3). This algo-
rithm was developed based on the experience with the herein 
reported cases at our institution and is since then implemented 
in clinical practice. Immediate echocardiography is necessary 
to confirm a persistently closed aortic valve and to evaluate for 
the presence of aortic root thrombi. With no signs of throm-
botic material, measures to regain pulsatile flow across the 
aortic valve should be taken by correcting possible hypovole-
mia, rhythm disturbances, or pericardial filling restraints and 
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by addressing and optimizing 
pump speed, LV contractility 
and loading conditions besides 
optimizing anticoagulation 
(Fig. 3). The strategy to restore 
pulsatile flow encompasses the 
reduction of femoral veno-
arterial ECMO flow to the 
absolute minimum needed 
to maintain vital organ per-
fusion (oxygen saturation in 
the venous ECMO cannula of 
60% is advisable, repetitively 
check lactate level), inotro-
pic, and possibly additional 
afterload reducing drugs. 
Weaning of femoral veno-
arterial ECMO support is of 
paramount importance. If 
ongoing mechanical circula-
tory support is needed, switch-
ing to a centrally cannulated 
veno-arterial ECMO or to a 
left axial flow device like the 
Impella (CP/5.0; Abiomed, 
Inc., Danvers, MA) could be 
treatment options. If periph-
eral venoarterial ECMO needs 
to be left in place, the addi-
tional implantation of a left 
axial flow pumps (Impella 2.5/
CP) will enhance LV unload-
ing and provide flow in the 
ascending aorta (25). Another 
option is the insertion of an 
IABP in addition to peripheral 
venoarterial ECMO support, 
but only if aortic valve open-
ing can be demonstrated with 
echocardiography. We strongly 
discourage from inserting a 
transseptal left atrial drainage 
catheter, an atrial septostomy 
or a TandemHeart (Cardiac 
Assist, Inc.; Pittsburgh, PA), as 
these interventions will likely 
enhance the nonejecting status 
by volume/preload reduction 
in the left atrium.
In case of high suspicion 
for aortic root thrombo-
sis, the treatment strategy 
must urgently be individual-
ized to the patients’ general 
condition and prognosis in 
Figure 3. Flowchart depicting an algorithm to detect and treat the state of a nonejecting during femoral veno-
arterial extracorporeal membrane oxygenation (VA ECMO) support. In situations with undetectable pulsatile 
flow in the peripheral arterial blood pressure tracing, we recommend to immediate echocardiography to confirm 
a persistently closed aortic valve (AV) and to evaluate the presence of thrombus. With no signs of thrombotic 
material, measures to regain pulsatile should be taken. The strategy to restore pulsatile flow encompasses the 
reduction of femoral VA ECMO flow to the absolute minimum needed to maintain vital organ perfusion (oxygen 
saturation in the venous ECMO cannula of 60% is advisable, repetitively check lactate level), inotropic and 
possibly afterload reducing drugs. Weaning of femoral VA ECMO support is of paramount importance. If ongoing 
mechanical circulatory support is needed, switching to a centrally cannulated VA ECMO or to a left axial flow 
device like the Impella (CP/5.0) are valuable treatment options. If peripheral VA ECMO needs to be left in place, 
the additional implantation of a left axial flow pumps (Impella 2.5/CP) will enhance left ventricle (LV) unloading 
and provide flow in the ascending aorta (25). In case of high suspicion for aortic root thrombosis, the treatment 
strategy must urgently be individualized to the patients’ general condition and prognosis in a multidisciplinary 
approach. The decision to either aim for AV reopening or to suppress pulsatile flow depends on the time of lost 
pulsatility, the size and location of the possible thrombus. In selected cases, urgent heart transplantation or the 
implantation of a permanent LV assist device may be treatment options. CP = cardiac power, IABP = intra-aortic 
balloon pump, LVAD = left ventricular assist device, TOE = transesophageal echocardiography.
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a multidisciplinary approach. The decision to either aim for 
aortic valve reopening or to suppress pulsatile flow depends on 
the time of lost pulsatility, the size and location of the possible 
thrombus, complicating factors as pericardial effusion and 
rhythm disturbances, and most importantly the underlying 
disease and general prognosis of the patient (26–29). Hence, 
clear-cut echocardiographic distinction between thrombus in 
formation (with potentially already present microthrombi) 
and firm thrombus is often impossible. Treatment decisions in 
such cases should be made by experienced physicians based on 
multidisciplinary discussion. If one aims for surgical throm-
bectomy, high ECMO pump speeds are advised to prevent aor-
tic valve opening until urgent surgery. In selected cases, urgent 
heart transplantation or the implantation of a permanent LV 
assist device may be treatment options.
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